Marzio Frazzoni
Research Subjects
Marzio Frazzoni has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Edoardo Savarino
Gastroenterology Unit Azienda Ospedale Università di Padova Padua Italy
15 shared publications- Nicola de Bortoli
Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa Pisa Italy
15 shared publications Rita Conigliaro
Digestive Pathophysiology Unit and Digestive Endoscopy Unit Azienda Ospedaliero Universitaria di Modena, Ospedale Civile di Baggiovara Modena Italy
12 shared publications- Edoardo Savarino
Department of Surgery, Oncology and Gastroenterology University of Padova Padova Italy
11 shared publications Leonardo Frazzoni
Gastroenterology Unit, Department of Medical and Surgical Sciences IRCCS Azienda Ospedaliero‐Universitaria di Bologna, Policlinico S Orsola‐Malpighi Bologna Italy
11 shared publications- Mentore Ribolsi
Department of Digestive Diseases Campus Bio Medico University of Rome Roma Italy
10 shared publications
Latest Publications
- 9 April 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 59 (9) , 1150-1151
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply'
LINKED CONTENT: This article is linked to Calabrese et al papers. To view these articles, visit https://doi.org/10.1111/apt.17934 and https://doi.org/10.1111/apt.17955
- 9 April 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 59 (9) , 1150-1151
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply'
LINKED CONTENT: This article is linked to Calabrese et al papers. To view these articles, visit https://doi.org/10.1111/apt.17934 and https://doi.org/10.1111/apt.17955
- 6 March 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 59 (9) , 1134-1143
Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study
Summary: Background: The diagnosis of gastro‐oesophageal reflux disease (GERD) based on otolaryngologist's assessment of laryngoscopic findings remains contentious in terms of sensitivity and specificity.Aims: To evaluate GERD prevalence, applying Lyon 2.0 Consensus criteria, in patients with extra‐oesophageal symptoms undergoing laryngoscopic examination and impedance‐pH monitoring.Methods: In this retrospective assessment, we included 470 patients with extra‐oesophageal symptoms, either isolated or combined with typical symptoms, who had been referred to six tertiary Italian Gastroenterology Units between January and December 2020. Of these, 274 underwent 24‐h impedance‐pH monitoring and laryngoscopy off PPI therapy. GERD diagnosis followed Lyon Consensus 2.0 criteria, incorporating mean nocturnal baseline impedance when pH‐impedance monitoring was inconclusive.Results: Laryngoscopic examination revealed pathological findings (predominantly posterior laryngitis) in 71.2% (195/274). GERD was diagnosed in 29.2% (80/274) via impedance‐pH monitoring. The prevalence of GERD in patients with positive or negative laryngoscopy was similar (32.3% vs. 21.5%, p = 0.075). No significant difference in proximal reflux occurrences was noted between positive and negative laryngoscopy groups (33.3% vs. 24.1%, p = 0.133). Laryngoscopy demonstrated sensitivity and specificity of 78.8% and 32.0%, respectively, with a positive predictive value (PPV) of 32.3% and negative predictive value (NPV) of 28.4%. In contrast, a threshold of four concurrent laryngoscopic signs, identified in only eight patients, demonstrated a PPV of 93.8% and a NPV of 73.6% (sensitivity 25.4%, specificity 99.2%).Conclusion: This study underscores the limited diagnostic accuracy of laryngoscopy, emphasising the necessity of impedance‐pH monitoring for confirming GERD diagnoses using Lyon 2.0 criteria in patients with suspected extra‐oesophageal symptoms.
- 6 March 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 59 (9) , 1134-1143
Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study
Summary: Background: The diagnosis of gastro‐oesophageal reflux disease (GERD) based on otolaryngologist's assessment of laryngoscopic findings remains contentious in terms of sensitivity and specificity.Aims: To evaluate GERD prevalence, applying Lyon 2.0 Consensus criteria, in patients with extra‐oesophageal symptoms undergoing laryngoscopic examination and impedance‐pH monitoring.Methods: In this retrospective assessment, we included 470 patients with extra‐oesophageal symptoms, either isolated or combined with typical symptoms, who had been referred to six tertiary Italian Gastroenterology Units between January and December 2020. Of these, 274 underwent 24‐h impedance‐pH monitoring and laryngoscopy off PPI therapy. GERD diagnosis followed Lyon Consensus 2.0 criteria, incorporating mean nocturnal baseline impedance when pH‐impedance monitoring was inconclusive.Results: Laryngoscopic examination revealed pathological findings (predominantly posterior laryngitis) in 71.2% (195/274). GERD was diagnosed in 29.2% (80/274) via impedance‐pH monitoring. The prevalence of GERD in patients with positive or negative laryngoscopy was similar (32.3% vs. 21.5%, p = 0.075). No significant difference in proximal reflux occurrences was noted between positive and negative laryngoscopy groups (33.3% vs. 24.1%, p = 0.133). Laryngoscopy demonstrated sensitivity and specificity of 78.8% and 32.0%, respectively, with a positive predictive value (PPV) of 32.3% and negative predictive value (NPV) of 28.4%. In contrast, a threshold of four concurrent laryngoscopic signs, identified in only eight patients, demonstrated a PPV of 93.8% and a NPV of 73.6% (sensitivity 25.4%, specificity 99.2%).Conclusion: This study underscores the limited diagnostic accuracy of laryngoscopy, emphasising the necessity of impedance‐pH monitoring for confirming GERD diagnoses using Lyon 2.0 criteria in patients with suspected extra‐oesophageal symptoms.
- 29 February 2024
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 36 (5) , e14775
Proximal esophageal impedance baseline increases the yield of impedance‐pH and is associated with response to PPIs in chronic cough patients
Background: Chronic cough significantly impairs the quality of life. Although various studies focused on MNBI as assessed in the distal esophagus, scarce data are available on the clinical value of proximal measurements.Aim: To investigate the role of proximal MNBI in the workup of patients with chronic cough and its ability to predict PPI response.Methods: Demographic, clinical, endoscopy findings, impedance‐pH and HRM tracings from consecutive cough patients were evaluated. MNBI was calculated at proximal and distal esophagus.Results: One hundred and sixty four patients were included. In addition to traditional variables, when considering also the PSPW index or MNBI at 3 cm or 15 cm, the proportion of patients with pathological impedance‐pH monitoring significantly increased. 70/164 patients were responders, while 94 (57.3%) were non‐responder to double PPI dose (p < 0.05). Patients with pathologic MNBI at 3 cm and/or 15 cm as well as those with pathologic PSPW index were characterized by a significantly higher proportion of responders than that observed among patients with normal impedance‐pH variables (p < 0.001). The proportion of responders with pathological MNBI at 15 cm was significantly higher than the proportion of responders with pathological MNBI at 3 cm (82.8% vs. 64.3%, p < 0.05). At multivariable model, pathological MNBI at both 3 cm and 15 cm as well as PSPW index were associated with PPI responsiveness. The strongest association with PPI response was observed for MNBI at 15 cm.Conclusions: The assessment of MNBI at proximal esophagus increases the diagnostic yield of impedance‐pH monitoring and may represent a useful predictor of PPI responsiveness in the cumbersome clinical setting of suspected reflux‐related cough.
- 29 February 2024
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 36 (5) , e14775
Proximal esophageal impedance baseline increases the yield of impedance‐pH and is associated with response to PPIs in chronic cough patients
Background: Chronic cough significantly impairs the quality of life. Although various studies focused on MNBI as assessed in the distal esophagus, scarce data are available on the clinical value of proximal measurements.Aim: To investigate the role of proximal MNBI in the workup of patients with chronic cough and its ability to predict PPI response.Methods: Demographic, clinical, endoscopy findings, impedance‐pH and HRM tracings from consecutive cough patients were evaluated. MNBI was calculated at proximal and distal esophagus.Results: One hundred and sixty four patients were included. In addition to traditional variables, when considering also the PSPW index or MNBI at 3 cm or 15 cm, the proportion of patients with pathological impedance‐pH monitoring significantly increased. 70/164 patients were responders, while 94 (57.3%) were non‐responder to double PPI dose (p < 0.05). Patients with pathologic MNBI at 3 cm and/or 15 cm as well as those with pathologic PSPW index were characterized by a significantly higher proportion of responders than that observed among patients with normal impedance‐pH variables (p < 0.001). The proportion of responders with pathological MNBI at 15 cm was significantly higher than the proportion of responders with pathological MNBI at 3 cm (82.8% vs. 64.3%, p < 0.05). At multivariable model, pathological MNBI at both 3 cm and 15 cm as well as PSPW index were associated with PPI responsiveness. The strongest association with PPI response was observed for MNBI at 15 cm.Conclusions: The assessment of MNBI at proximal esophagus increases the diagnostic yield of impedance‐pH monitoring and may represent a useful predictor of PPI responsiveness in the cumbersome clinical setting of suspected reflux‐related cough.
- 19 May 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (8) , e14612
Proximal esophageal impedance baseline increases the yield of impedance‐pH monitoring for GERD diagnosis and is associated with heartburn response to PPI
Background: Impairment of esophageal mucosal integrity as assessed by low mean nocturnal baseline impedance (MNBI) measured in the distal esophagus increases the diagnostic yield of impedance‐pH in patients with inconclusive GERD diagnosis as defined by Lyon criteria.Aim: To assess the diagnostic yield of MNBI measurement in the proximal esophagus, and its relationship with PPI response.Methods: Expert review of off‐therapy impedance‐pH tracings from consecutive patients with heartburn, 80 responders and 80 non‐responders to label‐dose PPI. Data were compared to those from 36 healthy controls using ROC analysis. Multivariate analysis was performed to measure the strength of association of MNBI with PPI response.Results: A threshold value of 2665 Ω was defined for proximal MNBI by ROC analysis, affording 91.7% sensitivity and 86.5% specificity. Proximal and distal MNBI were significantly lower in non‐responder cases as compared to responders. Adding proximal MNBI positivity to pathologic (>6%) acid exposure time (AET) and positive symptom‐reflux association, the proportion of patients with abnormal impedance‐pH findings increased from 74/160 (46%) to 106/160 (66.3%) (p = 0.0016). Among the 12 patients with pathologic proximal MNBI as the only positive impedance‐pH finding, 9 cases (75%) were PPI responders. According to multivariate analysis, AET and pathological distal and proximal MNBI were significantly associated with PPI response, the strongest association observed for proximal MNBI.Conclusions: Impedance baseline assessment in the proximal esophagus may increase the diagnostic yield of impedance‐pH monitoring. Heartburn response to PPI is directly related to ultrastructural mucosal damage in the distal and in the proximal esophagus as well.
- 19 May 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (8) , e14612
Proximal esophageal impedance baseline increases the yield of impedance‐pH monitoring for GERD diagnosis and is associated with heartburn response to PPI
Background: Impairment of esophageal mucosal integrity as assessed by low mean nocturnal baseline impedance (MNBI) measured in the distal esophagus increases the diagnostic yield of impedance‐pH in patients with inconclusive GERD diagnosis as defined by Lyon criteria.Aim: To assess the diagnostic yield of MNBI measurement in the proximal esophagus, and its relationship with PPI response.Methods: Expert review of off‐therapy impedance‐pH tracings from consecutive patients with heartburn, 80 responders and 80 non‐responders to label‐dose PPI. Data were compared to those from 36 healthy controls using ROC analysis. Multivariate analysis was performed to measure the strength of association of MNBI with PPI response.Results: A threshold value of 2665 Ω was defined for proximal MNBI by ROC analysis, affording 91.7% sensitivity and 86.5% specificity. Proximal and distal MNBI were significantly lower in non‐responder cases as compared to responders. Adding proximal MNBI positivity to pathologic (>6%) acid exposure time (AET) and positive symptom‐reflux association, the proportion of patients with abnormal impedance‐pH findings increased from 74/160 (46%) to 106/160 (66.3%) (p = 0.0016). Among the 12 patients with pathologic proximal MNBI as the only positive impedance‐pH finding, 9 cases (75%) were PPI responders. According to multivariate analysis, AET and pathological distal and proximal MNBI were significantly associated with PPI response, the strongest association observed for proximal MNBI.Conclusions: Impedance baseline assessment in the proximal esophagus may increase the diagnostic yield of impedance‐pH monitoring. Heartburn response to PPI is directly related to ultrastructural mucosal damage in the distal and in the proximal esophagus as well.
- 13 February 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (5) , e14547
On‐therapy impedance‐pH monitoring can efficiently characterize PPI‐refractory GERD and support treatment escalation
Background: On‐therapy impedance‐pH monitoring is recommended in patients with documented GERD and PPI‐refractory heartburn in order to establish whether the unremitting symptom is reflux‐related or not.Aims: To define on‐PPI cut‐offs of impedance‐pH metrics allowing proper interpretation of on‐therapy impedance‐pH monitoring.Methods: Blinded expert review of impedance‐pH tracings performed during double‐dosage PPI, prospectively collected from 150 GERD patients with PPI‐refractory heartburn and 45 GERD patients with PPI‐responsive heartburn but persisting extra‐esophageal symptoms. Acid exposure time (AET), number of total refluxes (TRs), post‐reflux swallow‐induced peristaltic wave (PSPW) index, and mean nocturnal baseline impedance (MNBI) were assessed. On‐PPI cut‐offs were defined and evaluated with ROC analysis and the area under curve (AUC).Results: All the four impedance‐pH metrics significantly differed between PPI‐refractory and PPI‐responsive heartburn cases. At ROC analysis, AUC was 0.73 for AET, 0.75 for TRs, 0.81 for PSPW index, and 0.71 for MNBI; best cut‐offs were ≥1.7% for AET, ≥45 for TRs, ≤36% for PSPW index, and ≤ 1847 Ω for MNBI; AUC of such cut‐offs was 0.66, 0.71, 0.73, and 0.68, respectively. Analysis of PSPW index and MNBI added to assessment of AET and TRs significantly increased the yield of on‐therapy impedance‐pH monitoring in the PPI‐refractory cohort (97% vs. 83%, p < 0.0001). Notably, suboptimal acid suppression as shown by AET ≥1.7% was detected in 43% of 150 PPI‐refractory cases.Conclusions: We have defined on‐PPI cut‐offs of impedance‐pH metrics by which comprehensive assessment of impedance‐pH tracings, including analysis of PSPW index and MNBI can efficiently characterize PPI‐refractory GERD and support treatment escalation.
- 13 February 2023
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (5) , e14547
On‐therapy impedance‐pH monitoring can efficiently characterize PPI‐refractory GERD and support treatment escalation
Background: On‐therapy impedance‐pH monitoring is recommended in patients with documented GERD and PPI‐refractory heartburn in order to establish whether the unremitting symptom is reflux‐related or not.Aims: To define on‐PPI cut‐offs of impedance‐pH metrics allowing proper interpretation of on‐therapy impedance‐pH monitoring.Methods: Blinded expert review of impedance‐pH tracings performed during double‐dosage PPI, prospectively collected from 150 GERD patients with PPI‐refractory heartburn and 45 GERD patients with PPI‐responsive heartburn but persisting extra‐esophageal symptoms. Acid exposure time (AET), number of total refluxes (TRs), post‐reflux swallow‐induced peristaltic wave (PSPW) index, and mean nocturnal baseline impedance (MNBI) were assessed. On‐PPI cut‐offs were defined and evaluated with ROC analysis and the area under curve (AUC).Results: All the four impedance‐pH metrics significantly differed between PPI‐refractory and PPI‐responsive heartburn cases. At ROC analysis, AUC was 0.73 for AET, 0.75 for TRs, 0.81 for PSPW index, and 0.71 for MNBI; best cut‐offs were ≥1.7% for AET, ≥45 for TRs, ≤36% for PSPW index, and ≤ 1847 Ω for MNBI; AUC of such cut‐offs was 0.66, 0.71, 0.73, and 0.68, respectively. Analysis of PSPW index and MNBI added to assessment of AET and TRs significantly increased the yield of on‐therapy impedance‐pH monitoring in the PPI‐refractory cohort (97% vs. 83%, p < 0.0001). Notably, suboptimal acid suppression as shown by AET ≥1.7% was detected in 43% of 150 PPI‐refractory cases.Conclusions: We have defined on‐PPI cut‐offs of impedance‐pH metrics by which comprehensive assessment of impedance‐pH tracings, including analysis of PSPW index and MNBI can efficiently characterize PPI‐refractory GERD and support treatment escalation.
- 4 July 2022
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 65, 102264
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis
- 4 July 2022
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 65, 102264
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis
- Open Access
- 25 June 2022
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 56 (4) , 606-613
Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction
Summary: Background: Chicago classification version 4.0 (CCv4.0) introduced stringent diagnostic criteria for oesophagogastric junction outflow obstruction (EGJOO), in order to increase the clinical relevance of the diagnosis, although this has not yet been demonstrated.Aims: To determine the prevalence of EGJOO using CCv4.0 criteria in patients with CCv3.0‐based EGJOO, and to assess if provocative manoeuvres can predict a conclusive CCv4.0 diagnosis of EGJOO.Methods: Clinical presentation, high resolution manometry (HRM) with rapid drink challenge (RDC), and timed barium oesophagogram (TBE) data were extracted for patients diagnosed with EGJOO as per CCv3.0 between 2018 and 2020. Patients were then re‐classified according to CCv4.0 criteria, using clinically relevant symptoms (dysphagia and/or chest pain), and abnormal barium emptying at 5 min on TBE. Receiver operating characteristic (ROC) analyses identified HRM predictors of EGJOO.Results: Of 2010 HRM studies, 144 (7.2%) fulfilled CCv3.0 criteria for EGJOO (median age 61 years, 56.9% female). Upon applying CCv4.0 criteria, EGJOO prevalence decreased to 1.2%. On ROC analysis, integrated relaxation pressure during RDC (RDC‐IRP) was a significant predictor of a conclusive EGJOO diagnosis by CCv4.0 criteria (area under the curve: 96.1%). The optimal RDC‐IRP threshold of 16.7 mm Hg had 87% sensitivity, 97.1% specificity, 95.7% negative predictive value and 91.3% positive predictive value for a conclusive EGJOO diagnosis; lower thresholds (10 mmHg, 12 mmHg) had better sensitivity but lower specificity.Conclusion: CCv4.0 criteria reduced the prevalence of EGJOO by 80%, thereby refining the diagnosis and identifying clinically relevant outflow obstruction. Elevated RDC‐IRP can predict conclusive EGJOO per CCv4.0.
- 25 June 2022
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 56 (4) , 606-613
Open AccessChicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction
Summary: Background: Chicago classification version 4.0 (CCv4.0) introduced stringent diagnostic criteria for oesophagogastric junction outflow obstruction (EGJOO), in order to increase the clinical relevance of the diagnosis, although this has not yet been demonstrated.Aims: To determine the prevalence of EGJOO using CCv4.0 criteria in patients with CCv3.0‐based EGJOO, and to assess if provocative manoeuvres can predict a conclusive CCv4.0 diagnosis of EGJOO.Methods: Clinical presentation, high resolution manometry (HRM) with rapid drink challenge (RDC), and timed barium oesophagogram (TBE) data were extracted for patients diagnosed with EGJOO as per CCv3.0 between 2018 and 2020. Patients were then re‐classified according to CCv4.0 criteria, using clinically relevant symptoms (dysphagia and/or chest pain), and abnormal barium emptying at 5 min on TBE. Receiver operating characteristic (ROC) analyses identified HRM predictors of EGJOO.Results: Of 2010 HRM studies, 144 (7.2%) fulfilled CCv3.0 criteria for EGJOO (median age 61 years, 56.9% female). Upon applying CCv4.0 criteria, EGJOO prevalence decreased to 1.2%. On ROC analysis, integrated relaxation pressure during RDC (RDC‐IRP) was a significant predictor of a conclusive EGJOO diagnosis by CCv4.0 criteria (area under the curve: 96.1%). The optimal RDC‐IRP threshold of 16.7 mm Hg had 87% sensitivity, 97.1% specificity, 95.7% negative predictive value and 91.3% positive predictive value for a conclusive EGJOO diagnosis; lower thresholds (10 mmHg, 12 mmHg) had better sensitivity but lower specificity.Conclusion: CCv4.0 criteria reduced the prevalence of EGJOO by 80%, thereby refining the diagnosis and identifying clinically relevant outflow obstruction. Elevated RDC‐IRP can predict conclusive EGJOO per CCv4.0.
- Open Access
- 16 April 2022
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 55 (9) , 1216-1217
Editorial: Lyon consensus metrics—towards personalised diagnosis of non‐erosive reflux disease: Authors' reply
- 16 April 2022
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 55 (9) , 1216-1217
Open AccessEditorial: Lyon consensus metrics—towards personalised diagnosis of non‐erosive reflux disease: Authors' reply
- 3 March 2022
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (1) , e14344
Association between post‐reflux swallow‐induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms
Background: Impedance‐pH monitoring allows evaluation of esophageal chemical clearance, a response to reflux elicited by the esophago‐salivary reflex, by means of the post‐reflux swallow‐induced peristaltic wave (PSPW) index; mucosal integrity can be evaluated by means of mean nocturnal baseline impedance (MNBI) and is regarded as a GERD marker. Currently, the relationship between PSPW index and MNBI has not yet been fully investigated and represents the aim of the present study.Methods: Impedance‐pH tracings from consecutive patients were reviewed. ROC analysis and multivariate regression models were generated to evaluate the association between acid exposure time (AET), total refluxes (TRs), PSPW index, and MNBI. Patients were classified by means of AET thresholds and symptom‐reflux association indexes into conclusive and inconclusive GERD, reflux hypersensitivity (RH), and functional heartburn (FH). Pathologic MNBI p < 0.001). At ROC analysis, a PSPW index cut‐off value of 53% was the best discriminator between normal from pathologic MNBI values (sensitivity 88%, specificity 86.4%). Considering AET cut‐off of 4% or 6%, a sensitivity of 80.7% and 46% and a specificity of 62.5% and 93.2% were found, respectively. According to multivariate analysis, AET >4% and PSPW index value <53% or <61% were significantly associated with pathologic MNBI values.Conclusions and Inferences: Esophageal chemical clearance is a major defense mechanism against reflux and its impairment represents a major determinant of reflux‐associated mucosal damage.
- 3 March 2022
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 35 (1) , e14344
Association between post‐reflux swallow‐induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms
Background: Impedance‐pH monitoring allows evaluation of esophageal chemical clearance, a response to reflux elicited by the esophago‐salivary reflex, by means of the post‐reflux swallow‐induced peristaltic wave (PSPW) index; mucosal integrity can be evaluated by means of mean nocturnal baseline impedance (MNBI) and is regarded as a GERD marker. Currently, the relationship between PSPW index and MNBI has not yet been fully investigated and represents the aim of the present study.Methods: Impedance‐pH tracings from consecutive patients were reviewed. ROC analysis and multivariate regression models were generated to evaluate the association between acid exposure time (AET), total refluxes (TRs), PSPW index, and MNBI. Patients were classified by means of AET thresholds and symptom‐reflux association indexes into conclusive and inconclusive GERD, reflux hypersensitivity (RH), and functional heartburn (FH). Pathologic MNBI p < 0.001). At ROC analysis, a PSPW index cut‐off value of 53% was the best discriminator between normal from pathologic MNBI values (sensitivity 88%, specificity 86.4%). Considering AET cut‐off of 4% or 6%, a sensitivity of 80.7% and 46% and a specificity of 62.5% and 93.2% were found, respectively. According to multivariate analysis, AET >4% and PSPW index value <53% or <61% were significantly associated with pathologic MNBI values.Conclusions and Inferences: Esophageal chemical clearance is a major defense mechanism against reflux and its impairment represents a major determinant of reflux‐associated mucosal damage.